Spurring Innovation in Rare Diseases

Teaser image for PhRMA's fact sheet on innovation in rare diseases

Although rare diseases each may individually only impact a relatively small number of patients, defined as less than 200,000 in the United States, their impact on public health is far-reaching. While the median number of patients with each rare disease is less than 10,000, rare diseases affect 30 million Americans – about 1 in 10.

Teaser image for PhRMA's fact sheet on innovation in rare diseases

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.